Health Affairs

The 340B Rebate Pilot Model: Weighing 340B Program Integrity Against Financial Stability For The Safety Net

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

FDA’s Plan to Speed Drug Reviews Risks Skepticism From Insurers

Drugs approved by the FDA’s expanding program to expedite reviews for products in line with the Trump administration’s agenda ...
WCVB Channel 5 Boston

FDA to offer faster drug reviews to companies promoting 'national priorities'

U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food ...
JD Supra

FDA Expands Early Alert Program to All Medical Devices

On September 29, 2025, the U.S. Food and Drug Administration (FDA) announced the expansion of its Early Alert program to include all medical devices. This expansion builds on a pilot program that ...

Trump’s drug pricing push sidelines Medicare negotiation program

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...
The Manila Times

Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study

Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a late-stage clinical drug platform company pioneering ...